Delivery Order SPE2DB25D3020-SPE2DB25FWFWK

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,564,451,440 units of naloxone hydrochloride 4 mg nasal spray, with a ceiling value of $1,693.49. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under the terms of an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,561,377,676 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 29, 2023, with a completion date of June 30, 2023. The contract has a ceiling value of $2,047.78 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of 4,564,816,824 units of NALOXONE HCL 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,866.58, was awarded on June 5, 2024 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,560,315,275 units of Naloxone HCL 4 mg Nasal Spray. The $2,556.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 21, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,565,803,531 units of Naloxone HCL 4 mg Nasal Spray by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,143.85 Firm Fixed Price delivery order was awarded on September 13, 2024, with a completion date of September 16, 2024. The contract is being issued by the Defense Logistics Agency (DLA), a defense agency, and does not utilize any set-aside requirements. Amerisourcebergen holds a...
This federal contract award is for the delivery of 4,563,167,381 units of NALOXONE HCL 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $5,347.15, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 21, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 22, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,565,067,892 units of Naloxone HCl 4 mg Nasal Spray. The $2,011.33 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. This contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,086.45, is for the delivery of 4,566,749,486 units of Naloxone HCl 4 mg Nasal Spray. The contract has a firm fixed price and an ultimate completion date of December 18, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of 4,559,669,970 units of Naloxone HCL 4 mg Nasal Spray 2s to the Defense Logistics Agency (DLA). The $21,883.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWFWK
    Delivery Order

This federal contract award is for the delivery of 4,567,222,939 units of Naloxone HCL 4 mg Nasal Spray 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,152.12, was awarded on February 10, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and runs through February 11, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 9:56 AM